Heidi Smith, DO
Sports Medicine · Manhattan, KSNPI 1093153819
Payments from drug & device makers
What this record shows
This record is dominated by education: $14,387 of the $16,020 with a category attached, or 89.8%. 13 manufacturers reported payments, led by Titan Surgical Group, LLC at 37.8% of the total. Reporting peaked in 2019 at $7,040 and has fallen 99.4% since, to $42 in 2025.
Across 34 payments — averaging $471.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Titan Surgical Group, LLC$6K
- Smith+Nephew$5K
- Gemini Mountain Medical, LLC$4K
- Acumed LLC$513
- Medical Device Business Services, Inc.$300
- Arthrex$169
- plus $407 from 7 others
What the payments were for
- Travel & lodging$9556%
- Food & beverage$6784%
- Education$14,38790%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Titan Surgical Group, LLC | 7 | $6,063 |
| Smith+Nephew | 2 | $5,000 |
| Gemini Mountain Medical, LLC | 1 | $3,568 |
| Acumed LLC | 4 | $513 |
| Medical Device Business Services, Inc. | 1 | $300 |
| Arthrex | 3 | $169 |
| Vericel Corporation | 7 | $149 |
| Avanos Medical | 1 | $114 |
| Zimmer Biomet | 2 | $42 |
| Fidia Pharma USA Inc. | 3 | $38 |
| KCI USA, Inc. | 1 | $34 |
| AbbVie | 1 | $17 |
| Steelhead Surgical Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,020 in reported general payments places this provider in the 70th percentile of 56 sports medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 136 | $766 |
| Naproxen | 140 | $406 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $278 |
| Cefadroxil | 41 | $212 |
| Cephalexin | 99 | $154 |
| Famotidine | 58 | $142 |
| Ondansetron Hcl | 83 | $126 |
| Meloxicam | 48 | $98 |
| Tramadol Hcl | 26 | $75 |
| Methylprednisolone | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Manhattan
- Trevor GaskillManhattan$5K
- Jennifer MalcolmManhattan$475
- Kirk McCulloughLeawood$649K
- Michael KhadaviOverland Park$278K
- James HalloranLeawood$170K
- Scott MullenKansas City$65K
- Kent DoanLeawood$53K
- Daniel ChernoffLeawood$47K
- Erik HenkelmanLawrence$46K
- Brandon BarndsOverland Park$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.